These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27595291)

  • 1. Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia.
    Herishanu Y; Polliack A; Shenhar-Tsarfaty S; Weinberger R; Gelman R; Ziv-Baran T; Zeltser D; Shapira I; Berliner S; Rogowski O
    Ann Med; 2017 Feb; 49(1):75-82. PubMed ID: 27595291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
    Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
    J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
    Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
    JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
    Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
    Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
    International CLL-IPI working group
    Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.
    Frey UH; Nückel H; Sellmann L; Siemer D; Küppers R; Dürig J; Dührsen U; Siffert W
    Clin Cancer Res; 2006 Oct; 12(19):5686-92. PubMed ID: 17020971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.
    Royle JA; Baade PD; Joske D; Girschik J; Fritschi L
    Br J Cancer; 2011 Sep; 105(7):1076-81. PubMed ID: 21847118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum C-reactive protein and overall survival of patients with osteosarcoma.
    Li X; Tian F; Wang F; Li Y
    Tumour Biol; 2015 Jul; 36(7):5663-6. PubMed ID: 25986475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second Myeloid Malignancies in a Large Cohort of Patients With Chronic Lymphocytic Leukemia: A Single Institution Experience.
    Chavez JC; Dalia S; Sandoval-Sus J; Kharfan-Dabaja MA; Al-Ali N; Komrokji R; Padron E; Corrales-Yepez G; Rock-Klotz J; Pinilla-Ibarz J
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S14-8. PubMed ID: 26297266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
    Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
    Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
    Golombick T; Diamond TH; Manoharan A; Ramakrishna R
    Integr Cancer Ther; 2016 Jun; 15(2):183-9. PubMed ID: 27154182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
    Rogers KA; Huang Y; Ruppert AS; Salem G; Stephens DM; Heerema NA; Andritsos LA; Awan FT; Byrd JC; Flynn JM; Maddocks KJ; Jones JA
    Br J Haematol; 2018 Jan; 180(2):259-266. PubMed ID: 29193006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic characterization and multivariate survival analysis of chronic lymphocytic leukemia in Taiwan.
    Chen PM; Lin SH; Fan SF; Chiou TJ; Hsieh RK; Yu IT; Liu JH
    Acta Haematol; 1997; 97(4):196-204. PubMed ID: 9158661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
    Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
    Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
    Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
    Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.